Biodronate 60mg Injection

About

Bisphosphonates are a class of drugs that inhibit bone resorption by osteoclasts. They bind strongly to hydroxyapatite crystals in bone, particularly at sites of active bone remodeling. When osteoclasts attempt to resorb bone containing bisphosphonates, they internalize the drug, which then interferes with their metabolic pathways, leading to osteoclast apoptosis and reduced bone turnover. This action makes them highly effective in treating conditions characterized by excessive bone breakdown, such as hypercalcemia of malignancy, bone metastases, and osteoporosis.

The potent anti-resorptive action of bisphosphonates helps to normalize calcium levels and reduce skeletal complications in various disease states. Their targeted accumulation in bone tissue ensures a sustained therapeutic effect, making them a cornerstone in the management of bone-related disorders, particularly in oncology.

Uses

• Treatment of hypercalcemia of malignancy.
• Prevention of skeletal-related events in patients with bone metastases from solid tumors.
• Treatment of Paget's disease of bone.
• Treatment of osteoporosis (for severe cases or specific types).

Directions For Use

Administered intravenously by a healthcare professional. Dosage and frequency depend on the specific condition being treated and the patient's renal function.

Benefits

• Effectively lowers elevated calcium levels in hypercalcemia.
• Reduces the incidence of skeletal complications in cancer patients.
• Decreases bone pain associated with metastases.
• Inhibits osteoclast activity and bone resorption.
• Improves bone mineral density in certain conditions.
• Long-lasting effects with intermittent dosing.

Side Effects

• Fever and flu-like symptoms (acute phase reaction)
• Nausea and vomiting
• Fatigue
• Bone, joint, or muscle pain
• Hypocalcemia (low calcium levels)
• Renal impairment (dose-dependent)
• Osteonecrosis of the jaw (ONJ) (rare but serious)
• Atypical femoral fractures (rare)
• Esophageal irritation (less common with IV)
• Headache
• Diarrhea
• Constipation

Safety Measures

• Alcohol - Excessive alcohol consumption can negatively impact bone health and may exacerbate gastrointestinal side effects.
• Pregnancy - Contraindicated in pregnancy due to potential for fetal harm, including skeletal abnormalities. Effective contraception is required.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if bisphosphonates are excreted in human milk and could pose risks to the infant.
• Liver - No specific dosage adjustment required for liver impairment. Use with caution in severe hepatic dysfunction.
• Kidney - Contraindicated in patients with severe renal impairment (e.g., creatinine clearance <30 mL/min). Dosage adjustments are necessary for moderate impairment.
• Lung - No specific safety concerns related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.